The article below may contain offensive and/or incorrect content.
The stroke byproduct acrolein activates the precursor of heparanase, an enzyme that degrades the glycocalyx in the blood-brain barrier.Article Correctness Is Author's Responsibility: Target for Stroke Therapy in Blood-Brain Barrier Discovered
The stroke byproduct acrolein activates the precursor of heparanase, an enzyme that degrades the glycocalyx in the blood-brain barrier.
